A Pragmatic Trial Comparing Empagliflozin and Dapagliflozin Through Cluster Randomization Embedded in the Electronic Health Record

PHASE4RecruitingINTERVENTIONAL
Enrollment

17,200

Participants

Timeline

Start Date

October 10, 2024

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions
Diabetes Mellitus, Type 2Heart FailureChronic Kidney Diseases
Interventions
DRUG

Empagliflozin 10 MG

Once daily

DRUG

Dapagliflozin 10 MG

Once daily

Trial Locations (12)

Unknown

RECRUITING

Bispebjerg Hospital, Copenhagen

RECRUITING

Rigshospitalet, Copenhagen

RECRUITING

Herlev and Gentofte Hospital, Herlev

RECRUITING

Steno Diabetes Center Copenhagen, Herlev

RECRUITING

Nordsjællands Hospital, Hillerød

RECRUITING

Holbæk Sygehus, Holbæk

RECRUITING

Hvidovre Hospital, Hvidovre

RECRUITING

Sjællands Universitetshospital, Køge

RECRUITING

Nykøbing F. Sygehus, Nykøbing Falster

RECRUITING

Sjællands Universitetshospital, Roskilde

RECRUITING

Bornholms Hospital, Rønne

RECRUITING

Slagelse Sygehus, Slagelse

All Listed Sponsors
lead

Herlev and Gentofte Hospital

OTHER